Uso de antihipertensivos como factor de riesgo para desarrollar la resistencia a eritropoyetina en pacientes con TRR - Hemodiálisis del HRHD - Arequipa

Files in this item

This item appears in the following Collection(s)

info:eu-repo/semantics/openAccess Except where otherwise noted, this item's license is described as info:eu-repo/semantics/openAccess